Middlefield Healthcare Dividend ETF

Fund Description

Middlefield Healthcare Dividend ETF is an actively managed, diversified fund comprised primarily of dividend-paying companies in the healthcare, life sciences and biotech industries.

Key Reasons to Invest:

  • exposure to an actively managed, low-cost fund which provides tax-efficient monthly distributions
  • a high conviction, diversified portfolio of companies operating in the global healthcare sector
  • healthcare is defensive as it provides needs-based products and services and also delivers growth and innovation through significant investments in R & D

MHCD 

Closing price  Ways To Invest Fact Sheet Prospectus (English) Prospectus (French) All Fund Documents

ETF Overview

  • Ticker/CUSIP:
    MHCD/59633Q103
  • Inception Date:
    July 21, 2017
  • Monthly Distribution:
    $0.05000
  • Advisor:
    Middlefield Capital Corporation
  • Industry Advisor:
    SSR - Dr.Richard Evans
  • Eligibility:
    All Registered and Non-Registered Accounts
  • Management Fee:
    0.85%
  • Risk Rating:
    Medium
  • Exchange:
    Toronto Stock Exchange

Industry Advisor

Fund Managers

Headshot of Robert Moffat
Robert Moffat
Portfolio Manager
Headshot of Dean Orrico
Dean Orrico
President and Chief Executive Officer

Performance

 
AS OF 1 MONTH 3 MONTHS 6 MONTHS YEAR-TO-DATE 1 YEAR 3 YEARS 5 YEARS 10 YEARS SINCE INCEPTION 2021 2020 2019 2018
December 31, 2022 -1.89% 8.38% 9.49% -0.73% -0.73% 7.95% 8.79% - 8.66% 14.54% 10.69% 12.76% 7.43%

Distributions

Total NAV & Distributions (since inception)  
Show More
RECORD DATE PAYMENT DATE PAYMENT AMOUNT
March 31, 2023 April 14, 2023 0.05
February 28, 2023 March 15, 2023 0.05
January 31, 2023 February 15, 2023 0.05
December 31, 2022 January 13, 2023 0.05
November 30, 2022 December 15, 2022 0.05
October 31, 2022 November 15, 2022 0.05
September 30, 2022 October 14, 2022 0.05
August 31, 2022 September 15, 2022 0.05
July 31, 2022 August 15, 2022 0.05
June 30, 2022 July 15, 2022 0.05

Fund Details

Sector Allocation (%)

As Of December 31, 2022
Pharmaceuticals 35.00%
Health Care Equipment 20.50%
Biotechnology 18.40%
Life Sciences Tools & Services 8.60%
Managed Health Care 5.50%
Health Care Distributors 4.80%
Health Care Services 3.00%
Office REITs 2.60%
Health Care Facilities 1.80%

Geographic Allocation (%)

As Of December 31, 2022
Canada 1.80%
U.S. 87.70%
International 10.50%

Top 10 Holdings

1 Merck & Co. 5.30%
2 Astrazeneca 5.00%
3 McKesson Corporation 4.80%
4 Eli Lilly and Company 4.70%
5 Abbvie Inc. 4.60%
6 Johnson & Johnson 4.50%
7 Thermo Fisher Scientific Inc. 4.40%
8 Danaher Corporation 4.20%
9 UnitedHealth Group 4.20%
10 Pfizer Inc. 4.10%
Close
Subscribe to Our Insights!
Flyout Form